Newsfiscal.ai
Baird Maintains Bright Minds Biosciences at Outperform, Lowers Price Target
· Published
Article summary
Baird analyst maintained an Outperform rating on Bright Minds Biosciences while reducing the price target from $126 to $107.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…